Abstract
Inverted papilloma (IP) is a common proliferation of squamous epithelial cells of the sinonasal tract. Although considered benign, IP is known to cause local destruction, has a high rate of recurrence, and a low, but significant rate of malignant transformation. Differentiating an IP from its histologic mimickers is essential for appropriate risk stratification and long-term surveillance. A classic case of sinonasal inverted papilloma is discussed.
Similar content being viewed by others
References
Barnes L. Schneiderianpapillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol. 2002;15(3):279–97. https://doi.org/10.1038/modpathol.3880524.
Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses: a clinicopathological study of 315 cases. Ann OtolRhinolLaryngol. 1971;80(2):192–206. https://doi.org/10.1177/000348947108000205.
Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the human papillomavirus in the pathogenesis of schneiderian inverted papillomas: an analytic overview of the evidence. Head and Neck Pathology. 2008;2(2):49–59. https://doi.org/10.1007/s12105-008-0048-3.
Hunt JL, Bell D, Sarioglu S, et al. Sinonasal papilloma, inverted type. In: Naggar A, Slootweg PJ, Chan JKC, et al., editors. World health classification of tumors: head and neck. Lyon: IARC Press; 2017. p. 18–9.
Norris HJ. Papillary lesions of the nasal cavity and paranasal sinuses. Laryngoscope. 1963. https://doi.org/10.1288/00005537-196301000-00001.
Ridolfi RL, Lieberman PH, Erlandson RA, Moore OS. Schneiderianpapillomas. Am J SurgPathol. 1977;1(1):43–54. https://doi.org/10.1097/00000478-197701010-00005.
Myers EN, Schramm VL, Barnes EL. Management of inverted papilloma of the nose and paranasal sinuses. Laryngoscope. 1981. https://doi.org/10.1288/00005537-198112000-00009.
Arnold A, Ziglinas P, Ochs K, Alter N, Geretschläger A, Lädrach K, Caversaccio M. Therapy options and long-term results of sinonasal malignancies. Oral Oncol. 2012;48(10):1031–7. https://doi.org/10.1016/j.oraloncology.2012.04.005.
Lewis JS, Westra WH, Thompson LD, Barnes L, Cardesa A, Hunt JL, Ferlito A. The sinonasal tract: another potential “hot spot” for carcinomas with transcriptionally-active human papillomavirus. Head and Neck Pathology. 2013;8(3):241–9. https://doi.org/10.1007/s12105-013-0514-4.
Furuta Y, Shinohara T, Sano K, Nagashima K, Inoue K, Tanaka K, Inuyama Y. Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope. 1991. https://doi.org/10.1288/00005537-199101000-00015.
Xiao-Ting W, Peng L, Xiu-Qing W, Hai-Bo W, Wen-Hui P, Bing L, Guang-Gang S. Factors affecting recurrence of sinonasal inverted papilloma. Eur Arch Otorhinolaryngol. 2012;270(4):1349–53. https://doi.org/10.1007/s00405-012-2216-z.
Kaufman MR, Brandwein MS, Lawson W. Sinonasalpapillomas: clinicopathologic review of 40 patients with inverted and oncocyticschneiderianpapillomas. The Laryngoscope. 2002;112(8):1372–7. https://doi.org/10.1097/00005537-200208000-00009.
Adriaensen GFJPM, Lim K-H, Georgalas C, Reinartz SM, Fokkens WJ. Challenges in the management of inverted papilloma: a review of 72 revision cases. Laryngoscope. 2016;126:322–8.
Philpott CM, Dharamsi A, Witheford M, Javer AR. Endoscopic management of inverted papillomas: long-term results–the St. Paul’s Sinus Centre experience. Rhinology. 2010;48:358–63.
Chai CK, Tang IP, Prepageran N. A review of inverted papilloma at a tertiary centre: a six-year experience. Int J Otolaryngol and Head Neck Surg. 2013;02:156.
Kim D-Y, Hong S-L, Lee CH, Jin H-R, Kang JM, Lee B-J, et al. Inverted papilloma of the nasal cavity and paranasal sinuses: a Korean multicenter study. Laryngoscope. 2012;122:487–94.
Healy DY, Chhabra N, Metson R, Holbrook EH, Gray ST. Surgical risk factors for recurrence of inverted papilloma. Laryngoscope. 2016;126:796–801.
Mak W, et al. Sinonasal inverted papilloma recurrence rates and evaluation of current staging systems. Rhinology. 2018;56(4):407.
Bhalla R. Predicting the site of attachment of sinonasal inverted papilloma. Rhinol J. 2009. https://doi.org/10.4193/rhin08.229.
Maroldi R, Farina D, Palvarini L, Lombardi D, Tomenzoli D, Nicolai P. Magnetic resonance imaging findings of inverted papilloma: differential diagnosis with malignant sinonasal tumors. Am J Rhinol. 2004;18(5):305–10. https://doi.org/10.1177/194589240401800508.
Nudell J, Chiosea S, Thompson LD. Carcinoma ex-schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol. 2014;8(3):269–86. https://doi.org/10.1007/s12105-014-0527-7.
Thompson L. Schneiderian papilloma of the sinonasal tract. Ear Nose Throat J. 2015;94(4–5):146–8.
Vorasubin N, Vira D, Suh JD, Bhuta S, Wang MB. Schneiderianpapillomas: comparative review of exophytic, oncocytic, and inverted types. Am J Rhinol Allergy. 2013;27(4):287–92. https://doi.org/10.2500/ajra.2013.27.3904.
Agrawal SR, Joshi AA, Dhorje N, Bradoo R. Respiratory epithelial adenomatoidhamartoma: a diagnostic challenge in sinonasal lesions. BMJ Case Rep. 2019. https://doi.org/10.1136/bcr-2019-230082.
Zhao R, Guo Z, Zhang R. Human papillomavirus infection and the malignant transformation of sinonasal inverted papilloma: a meta-analysis. J ClinVirol. 2016;79:36–43. https://doi.org/10.1016/j.jcv.2016.04.001.
Rooper LM, Bishop JA, Westra WH. Transcriptionally active high-risk human papillomavirus is not a common etiologic agent in the malignant transformation of inverted schneiderianpapillomas. Head Neck Pathol. 2017;11(3):346–53. https://doi.org/10.1007/s12105-017-0779-0.
Elliot A, Näsman A, Westman M, Hammarstedt-Nordenvall L, Stjärne P, Marklund L. Stathmin and EGFR correlates to HPV status and clinical outcome in sinonasal inverted papilloma. Rhinol J. 2019. https://doi.org/10.4193/rhin19.078.
Udager AM, Rolland DC, Mchugh JB, Betz BL, Murga-Zamalloa C, Carey TE, Brown NA. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Can Res. 2015;75(13):2600–6. https://doi.org/10.1158/0008-5472.can-15-0340.
Mehrad M, Stelow EB, Bishop JA, Wang X, Haynes W, Oliver D, Lewis JS. Transcriptionally active HPV and targetable egfr mutations in sinonasal inverted papilloma. Am J SurgPathol. 2020;44(3):340–6. https://doi.org/10.1097/pas.0000000000001411.
Peng R, Thamboo A, Choby G, Ma Y, Zhou B, Hwang PH. Outcomes of sinonasal inverted papilloma resection by surgical approach: an updated systematic review and meta-analysis. Int Forum Allergy Rhinol. 2019;9(6):573–81. https://doi.org/10.1002/alr.22305.
Goudakos JK, Blioskas S, Nikolaou A, Vlachtsis K, Karkos P, Markou KD. Endoscopic resection of sinonasal inverted papilloma: systematic review and meta-analysis. Am J Rhinol Allergy. 2018;32(3):167–74. https://doi.org/10.1177/1945892418765004.
Funding
This study has no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Frederic C. Jewett declares that he has no conflict of interest. Michael Coulter declares that he has no conflict of interest. Brenda L. Nelson declares that he has no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclaimer
The opinions and assertions expressed herein are those of the authors and are not to be construed as official or representing the views of the Department of the Navy or the Department of Defense.
Rights and permissions
About this article
Cite this article
Jewett, F.C., Coulter, M.J. & Nelson, B.L. Sine Qua Non: Sinonasal Inverted Papilloma. Head and Neck Pathol 15, 950–954 (2021). https://doi.org/10.1007/s12105-021-01289-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-021-01289-6